Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05936619 · ClinicalTrials.gov registry record · NA
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
A NA study of Paralysis; Quadriplegic, sponsored by Nader Pouratian.
- Recruiting
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT05936619 is a NA study of Paralysis; Quadriplegic that is actively recruiting participants, run by Nader Pouratian. The registered enrollment target is 2 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05936619, a NA study of Paralysis; Quadriplegic, is actively recruiting participants, sponsored by Nader Pouratian.
- RECRUITING
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being done to develop a novel brain-computer interface (BCI) technology that can enable severely paralyzed individuals to interact with the world through direct brain-control of a computer. This technology is named MindEx (for Mind Extender). It utilizes four implanted "chips" in the human brain from which investigators can record brain activity during subjects' thoughts and decode meaningful information from this activity to be used as control signals for a computer, a laptop, or a tablet. The use of four brain regions is a significant differentiating feature and scientific innovation of this study over much prior work in this space, that typically derived control signals from one, or sometimes two brain regions. The brain regions to be used here can allow the decode of multiple variables simultaneously, including not just moment-to-moment position, but also high-level goals, intentions, decisions, scene comprehension, and error-related signals involved in natural human behavior. The research is being done through a prospective, longitudinal, single-arm early feasibility study to examine the safety and effectiveness of using MindEx to provide the user an intuitive, efficient, and accurate ability to control multiple applications on a computer interface such as a word processor, a paint application, or to play simple video games. Such versatility could greatly improve the autonomy and quality of life of severely paralyzed individuals. Two subjects will be enrolled, each implanted with MindEx for a period of at least 53 weeks and up to 313 weeks. The study is expected to take at least one year and up to six years in total.
Conditions Studied
Interventions
- DEVICE Mind Extender (MindEx)
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2026-02-20 |
| Est. Completion | 2031-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05936619
The ClinicalTrials.gov registry entry for NCT05936619 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nader Pouratian, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paralysis; Quadriplegic appearing as the primary indexed condition, and to 1 intervention - of which Mind Extender (MindEx) is the first listed.
NCT05936619 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05936619 about?
NCT05936619 is a clinical study titled "MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System". This research study is being done to develop a novel brain-computer interface (BCI) technology that can enable severely paralyzed individuals to interact with the world through direct brain-control of a computer. This technology is named MindEx (for Mind Extender). It utilizes four implanted "chips"...
What is the current status of trial NCT05936619?
This trial is currently recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2026-02-20. Estimated completion is 2031-09-01.
What conditions does trial NCT05936619 study?
This clinical trial studies the following conditions: Paralysis; Quadriplegic.
What interventions are being tested in trial NCT05936619?
The interventions under investigation include: Mind Extender (MindEx) (DEVICE).
Who is sponsoring clinical trial NCT05936619?
This trial is sponsored by Nader Pouratian, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05936619 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.